NEWS

January 5, 2012,

Mahendra G. Shah, PhD, Joins Essentialis Board of Directors

December 12, 2011

Richards C. Pasternak, MD, Joins Essentialis Board of Directors

December 07, 2011

Aaron Berg Named CEO of Essentialis

October 25, 2010

Essentialis Receives Special Protocol Assessment Agreement from the FDA for Phase 3 Trial of DCCR

October 11, 2010 (VentureWire article)

Essentialis Taps Insiders For Series B, Shops Triglyceride Drug

October 11, 2010

Essentialis strengthens patent protection of its novel ATP-sensitive potassium channel opener portfolio

August 11, 2009 6:30 PM EDT

Essentialis to Submit SPA for Hypertriglyceridemia

May 17, 2009, 9:30 PM EDT

Essentialis Meets Primary Endpoint in Phase 2b tiral of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US

November 23, 2008 5:30 PM EDT

Essentialis Completes Patient Enrollment in Phase 2 Trial of DCCR for Treatment of Dyslipidemia

October 2, 2008 6:30 PM EDT

Essentialis Announces Two Presentations at Upcoming Conferences